International Emerging Markets - Regulation at the Jurisdictional Level

Jason Moscovici Related seminars and products

Partner, Lawyer, Biochemist

Robic, LLP

Jason Moscovici is a partner, lawyer and biochemist with ROBIC, LLP, a multidisciplinary intellectual property law firm from Quebec, Canada. His IP practice specializes in regulated industries such as food, alcohol, cannabis, pharmaceuticals, medical devices, cosmetics, natural health products, advertising and consumer products.

Jason’s focus on the valorization and enforcement of intellectual property, as well as the numerous compliance issues that orbit regulated industries, have allowed him to quickly become one of the most trusted legal advisors to the emerging cannabis industry. His perspectives on compliance, intellectual property and the commercial hurdles related specifically to cannabis are routinely solicited by stakeholders in this space.

Jason leads ROBIC`s cannabis group and sits on the life sciences committee of the firm.

Marie Sanchez Related seminars and products

Lawyer & Founder

Nooa Avocats

Marie has been a partner at DELCADE since 2022 and is a member of the Healthcare & Life Sciences team. Her activity is mainly focused on regulatory aspects related to Life Sciences.

Marie advises and represents the interests of various players in the Life Sciences sector (pharmaceutical companies, medical devices, nutraceuticals, cosmetics, food supplements, biocides, veterinary drugs, etc.) at all stages of the lifecycle of their products and services. She has also developed an in-depth expertise on regulatory and legal issues related to the emerging therapeutic cannabis and wellness hemp/CBD industries.

Her expertise spans advisory work on regulatory issues (general product regulation, clinical research, market access, product advertising, compliance, industry/healthcare professionals’ relations (anti-gift and transparency rules), vigilance, etc.) and on contractual matters. She also represents her clients in litigation before civil, commercial and administrative courts and assists them in their dealings with competent authorities (ANSM, CEPS, ANSES, ANMV, DGCCRF…). Her clients include companies of all sizes: large groups, SMEs and start-ups, both French and international.

A member of the Paris and Quebec Bars, Marie holds a Master II in Healthcare Industry Law from the University of Montpellier I, as well as an Executive MBA from ESSEC-Mannheim. After starting her career in Singapore with a major pharmaceutical group, she practiced for nearly 10 years in renowned international law firms before founding her own practice in 2020. She is a frequent speaker at international seminars and conferences on regulatory issues, particularly in relation to the cannabis industry. Outside the firm, Marie is a member of the International Cannabis Bar Association (INCBA) and the French Regulatory Affairs Association (AFAR).

Her motto:

“They did not know it was imposible, so they did it”  (Mark Twain)

Dr. Jayashree Mitra Related seminars and products

Partner

Fox Rothschild LLP

Jayashree is an accomplished intellectual property attorney with detailed knowledge of the pharmaceutical, biotech, legal cannabis, psychedelics and emerging technology sectors.

She represents clients in federal court and before the Patent Trial and Appeal Board (PTAB) and International Trade Commission in a full range of patent litigation, including Hatch-Waxman actions, Inter Partes Review (IPR) and Post Grant Review (PGR) proceedings and trade secrets disputes. She also has experience handling antitrust matters, as well as intellectual property due diligence and technology agreements for mergers, acquisitions and other corporate transactions.

A former neuropharmaceutical researcher at Yale University, Jayashree's technical knowledge extends to small molecules, protein therapeutics, protein conjugates, vaccines, injectables, biologics and biosimilars, as well as blockchain and data privacy. She is recognized as a Certified Information Privacy Professional/U.S. Private Sector (CIPP-US) by the International Association of Privacy Professionals.

Daniel Haymann, MBA Related seminars and products

Senior Associate

MLL Meyerlustenberger Lachenal Froriep Ltd

Daniel Haymann’s practice focuses on international and domestic commercial litigation and arbitration as well as corporate and commercial law.

He established the first dedicated cannabis desk at a large law firm in Switzerland and advises investors, start-ups and vertically integrated companies in the cannabis industry along the value chain, including, among others, on regulatory matters (advice includes all regulatory aspects relating to THC, CBD and other cannabinoids; cultivation and distribution, including GMP and GDP standards, as well as retail; EU Novel Food; cosmetics law; medicinal cannabis products under the supervisory authority Swissmedic (as well as Herbal Medicines)).

He gained extensive experience as a commodity trader and in managerial positions in the coal, petroleum coke and fertiliser industries for the two leading international commodity trading firms in their respective fields. He was based in Zurich, Baar, Singapore and Hong Kong. He then joined an International Finance and Business Development Boutique as partner and held management positions in corporate business development.